share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Recursion Pharmaceuticals | 4：持股變動聲明-高管 Secora Michael
美股SEC公告 ·  08/20 07:13
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals' Chief Financial Officer, Secora Michael, completed a sale of 11,962 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total market value of $80,025.78. Following the sale, Secora Michael directly holds 1,353,381 shares in the company. The sale was reported as a means to cover the payment of exercise price or tax liability by delivering or withholding securities.
Recursion Pharmaceuticals' Chief Financial Officer, Secora Michael, completed a sale of 11,962 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total market value of $80,025.78. Following the sale, Secora Michael directly holds 1,353,381 shares in the company. The sale was reported as a means to cover the payment of exercise price or tax liability by delivering or withholding securities.
Recursion Pharmaceuticals 致富金融（臨時代碼）的財務總監Secora Michael於2024年8月15日出售了公司11,962股A類普通股，成交價爲6.69美元/股，總市值爲80,025.78美元。交易完成後，Secora Michael直接持有公司1,353,381股。此次出售被報告爲通過交付或保留證券以支付行權價格或稅務負擔。
Recursion Pharmaceuticals 致富金融（臨時代碼）的財務總監Secora Michael於2024年8月15日出售了公司11,962股A類普通股，成交價爲6.69美元/股，總市值爲80,025.78美元。交易完成後，Secora Michael直接持有公司1,353,381股。此次出售被報告爲通過交付或保留證券以支付行權價格或稅務負擔。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間